Literature DB >> 7496920

Detection of borreliacidal antibody by using acridine orange and flow cytometry.

L C Lim1, Y F Liu, K Schell, S D Lovrich, S M Callister, R F Schell.   

Abstract

Borreliacidal antibody has been shown to be important for the serodiagnosis of Lyme disease and determination of immune status. Our results show that borreliacidal antibody can be rapidly and accurately detected by flow cytometry. Acridine orange was added to normal and immune sera containing Borrelia burgdorferi organisms in the presence and absence of complement prior to data acquisition by flow cytometry. The flow cytometric parameters of side scatter and detection of acridine orange fluorescence were used to determine events per minute (number of labeled spirochetes), percent shift in fluorescence (number of dead spirochetes), and mean channel fluorescence (intensity of fluorescence-labeled spirochetes) of acridine orange-labeled spirochetes. Borreliacidal antibody was detected as early as 4 h, with optimal detection 16 to 24 h after incubation of B. burgdorferi organisms with immune serum and complement. Our results also showed that complement was necessary for detection of borreliacidal antibody. Flow cytometry with acridine orange-labeled spirochetes provides a rapid means for detection of borreliacidal antibody.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496920      PMCID: PMC368194          DOI: 10.1128/cdli.1.1.44-50.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  An interlaboratory study of antibody to Borrelia burgdorferi.

Authors:  C W Hedberg; M T Osterholm; K L MacDonald; K E White
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

2.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

3.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

4.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

5.  Evaluation of a quantitative fluorescence immunoassay (FIAX) for detection of serum antibody to Borrelia burgdorferi.

Authors:  D R Pennell; P J Wand; R F Schell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

6.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass.

Authors:  D A Lee; J R Hoidal; C C Clawson; P G Quie; P K Peterson
Journal:  J Immunol Methods       Date:  1983-09-30       Impact factor: 2.303

8.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

9.  Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.

Authors:  R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

10.  Human phagocyte interactions with the Lyme disease spirochete.

Authors:  P K Peterson; C C Clawson; D A Lee; D J Garlich; P G Quie; R C Johnson
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more
  9 in total

1.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

2.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

3.  Rapid susceptibility testing of Candida albicans by flow cytometry.

Authors:  S M Kirk; S M Callister; L C Lim; R F Schell
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.

Authors:  M M Exner; X Wu; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.

Authors:  J R Jensen; B K Du Chateau; E L Munson; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.

Authors:  D A Jobe; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

Authors:  S D Lovrich; S M Callister; B K DuChateau; L C Lim; J Winfrey; S P Day; R F Schell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.